No abstract available
Keywords:
Adrenocortical carcinoma; PD-L1; hypercortisolism; immune checkpoints inhibitors; immunogenicity; immunotherapy; progression-free survival; tumor infiltrating lymphocytes.
Publication types
-
Editorial
-
Historical Article
MeSH terms
-
Adrenal Cortex Neoplasms / drug therapy*
-
Adrenal Cortex Neoplasms / genetics
-
Adrenal Cortex Neoplasms / immunology
-
Adrenal Cortex Neoplasms / mortality
-
Adrenocortical Carcinoma / drug therapy*
-
Adrenocortical Carcinoma / genetics
-
Adrenocortical Carcinoma / immunology
-
Adrenocortical Carcinoma / mortality
-
Clinical Trials as Topic
-
Disease Progression
-
Drug Resistance, Neoplasm / genetics
-
Drug Resistance, Neoplasm / immunology
-
History, 21st Century
-
Humans
-
Immune Checkpoint Inhibitors / pharmacology
-
Immune Checkpoint Inhibitors / therapeutic use*
-
Immunotherapy / history
-
Immunotherapy / methods*
-
Immunotherapy / trends
-
Progression-Free Survival
Substances
-
Immune Checkpoint Inhibitors